TWiV 1265: mRNA vaccines make cancer treatment great again
Oct 26, 2025•1 hr 51 min•Ep. 1265
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
TWiV explains studies showing that SARS-CoV-2 mRNA vaccines improve life span of cancer patients on checkpoint immunotherapy, and broad immunity conferred by a vaccine central in A(H5) influenza antigenic space.
Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy SpindlerSubscribe (free): Apple Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Support science education at MicrobeTV
- Immune 100 live at the Incubator
- SARS-CoV-2 mRNA vaccines sensitize tumors to checkpoint immunotherapy (Nature)
- People with some cancers live longer after mRNA vaccines (Nature)
- Immune checkpoint inhibitors (NCI)
- Broad immunity from influenza H5 vaccine (Nature)
- Derek Smith on antigenic cartography (TWiV 99 at 2:53)
- Letters read on TWiV 1265
- Timestamps by Jolene Ramsey. Thanks!
Kathy – Permethrin-treated baby wraps for malaria prevention and Phil Sharp and the Biotech Revolution Rich – Lydia Fairchild; Tetragametic Chimerism (NEJM) Alan – Warning Signs Vincent – radio.garden thanks to Kim!
Listener PickJamie – SkyCards by Flightradar24
Intro music is by Ronald Jenkees
Send your virology questions and comments to twiv@microbe.tv
Content in this podcast should not be construed as medical advice.
For the best experience, listen in Metacast app for iOS or Android